Lung Cancer
Volume 71, Issue 3 , Pages 306-311 , March 2011

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

  • Sacha I. Rothschild

      Affiliations

    • University of Bern, Department Clinical Research, 3010 Bern, Switzerland
    • University Hospital Bern, Department of Medical Oncology, 3010 Bern, Switzerland
    • ,
  • Andreas Kappeler

      Affiliations

    • University of Bern, Institute of Pathology, Murtenstrasse 31, 3010 Bern, Switzerland
    • ,
  • Daniel Ratschiller

      Affiliations

    • University Hospital Bern, Department of Medical Oncology, 3010 Bern, Switzerland
    • ,
  • Daniel C. Betticher

      Affiliations

    • Hospital of Fribourg, Clinic of Medical Oncology, 1700 Fribourg, Switzerland
    • ,
  • Mario P. Tschan

      Affiliations

    • University of Bern, Department Clinical Research, 3010 Bern, Switzerland
    • University Hospital Bern, Department of Medical Oncology, 3010 Bern, Switzerland
    • ,
  • Mathias Gugger

      Affiliations

    • University of Bern, Institute of Pathology, Murtenstrasse 31, 3010 Bern, Switzerland
    • Both authors contributed equally.
    • Corresponding Author InformationCorresponding author. Tel.: +41 31 632 99 30; fax: +41 31 632 99 38.
    • ,
  • Oliver Gautschi

      Affiliations

    • University of Bern, Department Clinical Research, 3010 Bern, Switzerland
    • University Hospital Bern, Department of Medical Oncology, 3010 Bern, Switzerland
    • Both authors contributed equally.

Received 3 May 2010 ,Revised 21 June 2010 ,Accepted 28 June 2010.

References 

  1. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med. 2004;10:387–392
  2. Bhattacharya R, Kowalski J, Larson AR, Brock M, Alani RM. Id1 promotes tumor cell migration in nonsmall cell lung cancers. J Oncol. 2010;856105
  3. Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, Green TP, et al. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res. 2008;68:2250–2258
  4. Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4:470–480
  5. Rothschild SI, Gautschi O, Haura EB, Johnson FM. Src inhibitors in lung cancer: current status and future directions. Clin Lung Cancer. 2010;11(4):238–242
  6. Kadesch T. Consequences of heteromeric interactions among helix–loop–helix proteins. Cell Growth Differ. 1993;4:49–55
  7. Perk J, Iavarone A, Benezra R. Id family of helix–loop–helix proteins in cancer. Nat Rev Cancer. 2005;5:603–614
  8. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001;61:5703–5706
  9. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer. 2003;104:677–682
  10. Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, et al. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol. 2007;38:1321–1329
  11. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res. 2004;10:2044–2051
  12. Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, et al. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer. 2009;125:2576–2585
  13. Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C, et al. Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res. 2008;14:2318–2325
  14. Nieborowska-Skorska M, Hoser G, Rink L, Malecki M, Kossev P, Wasik MA, et al. Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase-transformed leukemia cells. Cancer Res. 2006;66:4108–4116
  15. Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV, Salazar EP. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2008;27:220–231
  16. Sun X, Li C, Zhuang C, Gilmore WC, Cobos E, Tao Y, et al. Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells. Carcinogenesis. 2009;30:2109–2116
  17. Zhu W, Dahmen J, Bulfone A, Rigolet M, Hernandez MC, Kuo WL, et al. Id gene expression during development and molecular cloning of the human Id-1 gene. Brain Res Mol Brain Res. 1995;30:312–326
  18. Coppe JP, Smith AP, Desprez PY. Id proteins in epithelial cells. Exp Cell Res. 2003;285:131–145
  19. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–847
  20. Ratschiller D, Heighway J, Gugger M, Kappeler A, Pirnia F, Schmid RA, et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol. 2003;21:2085–2093
  21. Purnell PR, Mack PC, Tepper CG, Evans CP, Green TP, Gumerlock PH, et al. The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells. J Thorac Oncol. 2009;4(4):448–454
  22. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA. 2007;104:19506–19511
  23. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, et al. Differential expression of matrilysin-1 (MMP-7), 92kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol. 2004;202:14–22
  24. McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109:716–721
  25. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol. 2001;159:2249–2256
  26. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49–59
  27. Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, et al. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2007;97:1409–1415
  28. Rollin J, Blechet C, Regina S, Tenenhaus A, Guyetant S, Gidrol X. The intracellular localization of ID2 expression has a predictive value in non small cell lung cancer. PLoS One. 2009;4:e4158

☆ Presented in part at the World Conference on Lung Cancer; August 1–4, 2009 San Francisco (USA).

PII: S0169-5002(10)00319-3

doi: 10.1016/j.lungcan.2010.06.018

Lung Cancer
Volume 71, Issue 3 , Pages 306-311 , March 2011

Article Tools

* Image Usage & Resolution